UF Neuro Research Ranks No. 2 Nationally in NIH Funding
Neuroscience and neuromedicine research at the University of Florida ranked No. 2 in NIH funding among all public universities in the U.S., according to the Blue Ridge Institute for Medical Research’s 2023 rankings. With $31.8 million in NIH funding, UF neurosciences — a combined ranking of the departments of neuroscience and neurology — ranked No. 2 among public universities and No. 3 overall. In 2022, UF neurosciences ranked No. 3 among public universities and No. 5 overall.
UF Brain Institute Receives $1 Million for Stroke Research Project
The University of Florida’s McKnight Brain Institute received $1 million to support a stroke research project. The funds are part of UF President Ben Sasse’s $10.9 million strategic funding initiative aimed at boosting the university's position as a leader in critical research.
The funds will be used to launch a new project that utilizes AI to improve stroke treatments.
President’s Office Announces $10.9 Million for Third Round of Strategic Funding Awardees
UF President Ben Sasse announced a third round of strategic funding, which will see $10.9 million spread across 10 new projects aimed at solidifying UF's standing as a national research leader.
UF Neuroscientist Featured in Society for Neuroscience Annual Report
Research by Adam J. Woods, Ph.D., associate director of UF’s Center for Cognitive Aging and Memory, and collaborators using artificial intelligence to personalize transcranial direct current stimulation (tDCS) was highlighted in the Society for Neuroscience’s 2021 annual report.
UF Team Joins National Study of Brain Development in Infants, Children
The University of Florida is one of a network of institutions selected to implement the National Institutes of Health’s HEALthy Brain and Child Development (HBCD) Study or HBCD, a longitudinal, multidisciplinary effort to study brain development and behavioral health in young children, the NIH announced Thursday.
New Mouse-Model Research by UF Neuroscientists Provides Fresh Insight Into Parkinson’s Disease
New mouse-model research by University of Florida neuroscientists provides fresh insight into the impact of elevated levels of the protein alpha-synuclein on the function of dopamine-producing nerve cells, the progressive demise of which is associated with Parkinson’s disease.
UF Launches New State-of-the-Art Neuro-Oncology Lab
Top brain cancer researchers and University of Florida leaders unveiled a new, world-class neuro-oncology laboratory at UF’s Basic Science Building.
UF Neuroscientists Discover Biomarker With Potential To Aid Parkinson’s Diagnosis
University of Florida neuroscientists have developed a new assay, or test, to detect minute amounts of a protein called tyrosine hydroxylase in blood immune cells of Parkinson’s disease patients, a key finding to aid in the development of a blood test to help diagnose and guide treatment for the neurodegenerative disorder.
UF Neuroscience Expert Dr. Eduardo Candelario-Jalil Appointed on Emerald Health Pharmaceuticals Scientific Advisory Board
Emerald Health Pharmaceuticals Inc., a clinical-stage biotechnology company developing a new class of medicines to treat diseases with unmet medical needs, has expanded its Scientific Advisory Board with the appointment of University of Florida's neuroscience expert and innovator, Eduardo Candelario-Jalil, Ph.D.
New Study Tests Effectiveness of High-Intensity Exercise in Slowing Parkinson’s Symptoms
The University of Florida is collaborating on a new Phase 3 multisite clinical trial that will test the effectiveness of high-intensity and moderate-intensity treadmill exercise in slowing the progression of Parkinson’s disease symptoms.
